Navigation Links
Video: FDA Approves INVEGA(R) SUSTENNA(TM) for the Acute and Maintenance Treatment of Schizophrenia
Date:8/3/2009

ion and enables the formulation of an aqueous suspension for once-monthly intramuscular administration. INVEGA(R) SUSTENNA(TM) is manufactured by Janssen, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc, in the U.S.

About J&JPRD

INVEGA(R) SUSTENNA(TM) was developed by Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (J&JPRD), a member of the Johnson & Johnson family of companies, the world's most broadly-based producer of health care products. J&JPRD is headquartered in Raritan, N.J., and has facilities throughout Europe, the United States, and Asia. J&JPRD is leveraging drug discovery and drug development in a variety of therapeutic areas, including CNS, Internal Medicine, and Oncology, to address unmet medical needs worldwide. More information can be found at http://www.jnjpharmarnd.com.

About Janssen

Janssen, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc, is based in Titusville, N.J., and is the only large pharmaceutical company in the U.S. dedicated solely to mental health. It currently markets prescription medications for the treatment of schizophrenia, bipolar mania, schizoaffective disorder, and the treatment of symptoms associated with autistic disorders. Ortho-McNeil-Janssen Pharmaceuticals, Inc is a member of the Johnson & Johnson family of companies. For more information about Janssen, visit http://www.janssen.com/.

About NanoCrystal((R)) Technology and Elan Drug Technologies

INVEGA(R) SUSTENNA(TM) utilizes the NanoCrystal((R)) Technology, which is a proprietary technology developed by Elan Drug Technologies through Elan Pharma International Limited and other Elan affiliates. NanoCrystal((R)) Technology is a registered trademark of Elan Pharma International Limited, Ire
'/>"/>

SOURCE Janssen, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Video: New Dove(R) Body Washes with NutriumMoisture(TM) Restore Skins Natural Moisture
2. Video: Phase III Study Data With Vandetanib (Zactima(TM)) in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) Presented at American Society of Clinical Oncology
3. Video: Data on More Than 15 Novartis Oncology Compounds at ASCO Highlight Progress Toward Targeted Therapies for Diverse Tumor Types
4. Video: UCB Launches Vimpat(R) in the U.S. for Add-On Treatment of Epilepsy in Adults
5. Video: Partnership Unites UCB with Consumer Product Innovator OXO(R)
6. Video: ev3 Inc. Announces First Patient Enrollments in DEFINITIVE LE Post-Market Study
7. Video: Afinitor(R) Approved in US as First Treatment for Patients With Advanced Kidney Cancer After Failure of Either Sunitinib or Sorafenib
8. Video: Provectus PV-10 Interim Phase 2 Safety and Efficacy Results are as Good as or Better than Phase 1 Results
9. Video: Zometa(R) Reduces Risk of Breast Cancer Recurrence in Premenopausal Women, Study in The New England Journal of Medicine Reports
10. Video: Femara(R) First Aromatase Inhibitor to Indicate Survival Benefit Versus Tamoxifen When Taken for Five Years After Breast Cancer Surgery
11. Video: Tasigna(R) Demonstrates Rapid Response as Initial Therapy in Life-Threatening Form of Leukemia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... 2015  AVACEN, Inc. announced today the issue by the ... medical technology platform supporting its unique Dry Heat Therapy AVACEN ... Logo - http://photos.prnewswire.com/prnh/20150630/227364LOGO ... 9,066,781 - Methods And Apparatus For Therapeutic Application of Thermal ... methods of use, referred to by the company as the ...
(Date:7/1/2015)... 1, 2015 Radiant Insights announce ... Oxygen Concentrators Market Shares, Strategy, and Forecasts, Worldwide, ... continuing growth as the aging population worldwide needs homecare ... conditions where oxygen is able to improve the quality ... have become affordable and support a mobile lifestyle even ...
(Date:7/1/2015)... , July 1, 2015 ... is expected to reach USD 49,119.2 million by 2020, ... Inc. Monitoring services is expected to remain the dominant ... USD 1,227.5 million in 2012, and an estimated CAGR ... (Logo: http://photos.prnewswire.com/prnh/20150105/723757 ) , Browse full ...
Breaking Medicine Technology:AVACEN Medical Patent Issued 2Stationary Oxygen Concentrators Market to Reach $2 Billion by 2021: Radiant Insights, Inc. 2Stationary Oxygen Concentrators Market to Reach $2 Billion by 2021: Radiant Insights, Inc. 3Stationary Oxygen Concentrators Market to Reach $2 Billion by 2021: Radiant Insights, Inc. 4mHealth Market Worth $ 49,119.2 Million By 2020: Grand View Research, Inc. 2mHealth Market Worth $ 49,119.2 Million By 2020: Grand View Research, Inc. 3mHealth Market Worth $ 49,119.2 Million By 2020: Grand View Research, Inc. 4mHealth Market Worth $ 49,119.2 Million By 2020: Grand View Research, Inc. 5
... following statement,by Andrea Kavanagh, Director of the Pure Salmon ... publish a study tomorrow that,shows sea lice from open ... wild fish stocks., "This study confirms what we ... havoc on wild salmon populations. If outbreaks of these,parasites ...
... Results, SOUTH SAN FRANCICSO, Calif., Dec. 13 ... announced that its oral syk,kinase inhibitor, R788 (tamatinib ... Arthritis (RA) patients in a,recently completed Phase 2 ... 150mg po bid (orally, twice daily), showed higher ...
Cached Medicine Technology:Rigel's R788 Demonstrates Significant Improvement in Rheumatoid Arthritis in Phase 2 Clinical Study 2Rigel's R788 Demonstrates Significant Improvement in Rheumatoid Arthritis in Phase 2 Clinical Study 3Rigel's R788 Demonstrates Significant Improvement in Rheumatoid Arthritis in Phase 2 Clinical Study 4Rigel's R788 Demonstrates Significant Improvement in Rheumatoid Arthritis in Phase 2 Clinical Study 5Rigel's R788 Demonstrates Significant Improvement in Rheumatoid Arthritis in Phase 2 Clinical Study 6
(Date:7/1/2015)... ... 01, 2015 , ... Who doesn’t want a life filled with thriving positivity ... balance between work and life, and positive friendships and relationships? , Dr. Marsha ... Lives, Wellbeing in Doctors. , With a focus on solving the epidemic of ill-being ...
(Date:7/1/2015)... ... 01, 2015 , ... The Recovery Workforce Summit: 2015 PRA Annual Conference ... of The Atlantic, as a keynote on June 2nd in Philadelphia, PA. Stossel led ... personal story added power and reach to the essential message, while opening doors to ...
(Date:7/1/2015)... ... 01, 2015 , ... The Thule Atmos X4 offers protection with minimal bulk. ... lived up to Thule’s rigorous standards. Due to its Bi-ComponentArmor and ShockStop corners, it ... come to expect. , The Thule Atmos X4 has also been designed ...
(Date:7/1/2015)... ... July 01, 2015 , ... ... security solutions, has partnered with WIU Crossroads School in safeguarding its staff and ... AEDY (Alternative Education for Disruptive Youth) environment of Crossroads School heightens the potential ...
(Date:7/1/2015)... ... July 01, 2015 , ... This week the American Pharmacists ... at the Society for Human Resource Management (SHRM) Annual Conference and Exposition. PSM ... can reduce overall cost of care by approximately $1,000 per person with diabetes ...
Breaking Medicine News(10 mins):Health News:Medical Doctor Explains The Healthy Effects of a Positive Outlook in New Book 2Health News:Scott Stossel, Editor of The Atlantic, Addressed Mental Health Professionals on Reducing Prejudice and Discrimination 2Health News:Scott Stossel, Editor of The Atlantic, Addressed Mental Health Professionals on Reducing Prejudice and Discrimination 3Health News:Scott Stossel, Editor of The Atlantic, Addressed Mental Health Professionals on Reducing Prejudice and Discrimination 4Health News:Scott Stossel, Editor of The Atlantic, Addressed Mental Health Professionals on Reducing Prejudice and Discrimination 5Health News:WIU Crossroads School Chooses Help Alert Mobile Staff Duress Pendants from RF Technologies to Safeguard Staff and Students, De-escalate Altercations 2Health News:WIU Crossroads School Chooses Help Alert Mobile Staff Duress Pendants from RF Technologies to Safeguard Staff and Students, De-escalate Altercations 3Health News:APhA Foundation to Showcase Newly Introduced Patient Self-Management Solutions at the Society for Human Resource Management (SHRM) Annual Conference and Exposition 2
... in northeastern China, has suspended drinking water supply ... contamination by chemical spillage.// ,The city government ... by admitting that fears of water contamination in ... supply cut", the official China Daily said., ...
... American and Japanese scientists have successfully treated nerve damage ... stem cells, and hope to treat patients with an ... future.// ,The results of the new research suggest ... and functional recovery after nerve injury, thus offering an ...
... AIDS will exploit the unused power of thousands of individual ... identify drugs used to combat the Human Immunodeficiency Virus (HIV).// ... enlist about 100,000 computer users to donate the use of ... be idle., ,This is the second research ...
... Americans are contacting food-borne illnesses more by contaminated fruits ... advocates say.//, ,Common sources of food illnesses include ... humans and animals make their way into manure fertilizers. ... in Latin America, which is a substantial supplier of ...
... stone on December 1 for the country's first stem cell translational ... ,The centre is being set up in collaboration with ... The research focus will be on the use of bone ... of a variety of diseases, Dr George M Chandy, Director of ...
... safety of artificial sweeteners got an impetus when a ... that a rat study conducted by Italy’s Ramazzini Institute ... regulatory reviews conducted on aspartame. The U.S. Food & ... any changes in the use of aspartame. The study, ...
Cached Medicine News:Health News:Stem Cells From Hair Follicle To Repair Nerve Damage 2Health News:Vegetables And Fruits Cause More US Food Illnesses 2Health News:Aspartame, Artificial Sweetener, A Safe Bet! 2Health News:Aspartame, Artificial Sweetener, A Safe Bet! 3
... an OraSure HIV-1 Oral Specimen Collection Device is ... for HIV-1 antibodies. Testing with the OraSure HIV-1 ... needles and has been shown to be more ... specially treated cotton fiber pad attached to a ...
... benefits of TiMAX material have been applied to ... strength and an ultra-low profile combine to provide ... lower extremity. , ,This complete set of periarticular ... , Fibula Composite Plate , ...
The DePuy ACE Titanium Active Compression Plate offers ingenuity in the art of fracture management....
Corneal Marking Pen - Sterile. 10 pieces/box...
Medicine Products: